GPC4 and metabolic disease: The comparative analysis of ROC curves (presented in Figure 2) revealed that the Glypican-4/Fat Body Mass (%) ratio is a good predictor of metabolic disorders (with an 82% specificity level at the cut-off point being 70.00 pg/mL/%).